Business
Novanta Announces Financial Results for the Second Quarter 2026
Novanta Announces Financial Results for the Second Quarter
About this update from Novanta Inc.
Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the second quarter 2026. Financial Highlights Three Months Ended (In millions, except per share amounts) July 3, June 27, 2026 2025 GAAP Revenue $ 265.8 $ 241.0 Operating Income $ 18.1 $ 14.9 Net Income $ 12.5 $ 4.5 Diluted EPS $ 0.30 $ 0.12 Non-GAAP* Adjusted Operating Income $ 47.5 $ 40.7 Adjusted Diluted EPS $ 0.89 $ 0.76 Adjusted EBITDA $ 60.7 $ 52.2 *Reconciliations of GAAP to non-GAAP financial measures, as well as definitions for the non-GAAP financial measures included in this press release and the reasons for their use, are presented below. Second Quarter “Novanta delivered an exceptional second quarter, exceeding expectations across revenue, margins, and profitability,” said Matthijs Glastra, Chair and Chief Executive Officer. “Revenue increased 10.3% year-over-year to $266 million on a reported basis and grew 9.3% organically, marking our strongest organic growth quarter since the first quarter of 2023. We also delivered a strong Adjusted Gross Margin of 47%, and generated Adjusted EBITDA of $60.7 million, a 16.4% increase year-over-year, representing an Adjusted EBITDA margin of 22.8%.” For the second quarter of 2026, Novanta generated GAAP revenue of $265.8 million, an increase of $24.8 million or 10.3%, compared to prior year. Year-over-year changes in foreign currency exchange rates favorably impacted revenue by $2.4 million or 1.0%. Organic Revenue Growth, which excludes the net impact of changes in foreign currency exchange rates, was an increase of 9.3% (see “Organic Revenue Growth” in the non-GAAP reconciliations below). For the second quarter of 2026, GAAP operating income was $18.1 million, compared to $14.9 million in the prior year. GAAP net income was $12.5 million, compared to $4.5 million in the prior year. GAAP diluted earnings per share (“EPS”) was $0.30, compared to $0.12 in the prior year. Diluted weighted average shares outstanding was 41.2 million for the second quarter of 20...